Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ENDO INTERNATIONAL PLC ENDPQ

Healthcare Drug Manufacturers - Specialty & Generic
Endo International plc has filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code and is winding down its business. The Company has no business operations.

Recent & Breaking News (GREY:ENDPQ)

Endo Employees Participate in 3rd Annual "Endo Gives" Day of Volunteering, Giving Back to Local Communities Around the World

PR Newswire May 25, 2016

Endo Reports First Quarter 2016 Financial Results

PR Newswire May 5, 2016

Endo Announces Appointment of Douglas S. Ingram and Todd B. Sisitsky to its Board of Directors

PR Newswire May 5, 2016

Endo Announces Change to Senior Management Team

PR Newswire May 5, 2016

Endo Announces Appearances at Upcoming Conferences

PR Newswire May 3, 2016

Endo Announces U.S. District Court Ruling Upholding OPANA® ER Intellectual Property

PR Newswire May 2, 2016

Endo to Announce First Quarter 2016 Financial Results on May 5, 2016

Canada NewsWire April 22, 2016

Endo Provides Statement Regarding Expected FDA Approval Of Generic Voltaren® Gel Product

Canada NewsWire March 21, 2016

Endo Announces Presentation at Barclays Global Healthcare Conference

Canada NewsWire March 10, 2016

National Sports Commentator, Dr. Jerry Punch, Together with Men's Health Network and Endo Pharmaceuticals, Encourages Men with Peyronie's Disease to Ask About the Curve

Canada NewsWire March 9, 2016

Endo Provides Informational Frequently Asked Questions & Answers

Canada NewsWire March 2, 2016

Endo Reports Fourth Quarter And Full Year 2015 Financial Results

Canada NewsWire February 29, 2016

Endo Announces Launch Of BELBUCA(TM) (Buprenorphine) Buccal Film For Chronic Pain Management

Canada NewsWire February 22, 2016

Endo Announces Initiation of Phase 2B Clinical Trial of Collagenase Clostridium Histolyticum in Cellulite

Press Releases February 17, 2016

Endo to Announce Fourth Quarter 2015 Financial Results on February 29, 2016

Press Releases February 16, 2016

Endo Announces the Qualitest Scholarship Program

PR Newswire February 1, 2016

Endo Announces Appearances At Upcoming Conferences

PR Newswire December 21, 2015

Endo Announces Extension Of U.S. Rights For Voltaren® Gel

Canada NewsWire December 14, 2015

Endo Announces Appearance At The 27th Annual Piper Jaffray Healthcare Conference

Canada NewsWire November 25, 2015

Endo International plc Announces Conditional Redemption of All $400,000,000 Aggregate Principal Amount Outstanding of the Two Series of 7.00% Senior Notes due 2020

PR Newswire November 20, 2015